High-dose ascorbate sensitizes NSCLC and GBM cells to radio-chemotherapy

Posted by Dr Dan Carter, 6 May 2017 An April 2017 article in Cancer Cell adds further support for the use of IV Ascorbate to improve responses to conventional oncology treatments. Key points include: O2⋅− and H2O2 increase labile iron causing cancer cell-selective ascorbate toxicity Therapeutic levels of ascorbate are achievable and well tolerated in [...]

2017-12-21T03:53:51+00:00 May 6th, 2017|Categories: Uncategorized|

Problems with Cochrane reviews of diet and chronic disease

Posted by Dr Dan Carter, July 8, 2016 AS Truswell has clearly explained why Cochrane reviews can lead to misleading conclusions when dealing with the effects of diet, especially when chronic diseases are involved. The sum of evidence-based nutrition has to be more than a Cochrane-type meta-analysis of randomised controlled trials (RCTs). Most of the [...]

2018-01-18T01:38:06+00:00 July 8th, 2016|Categories: Uncategorized|

Poor and/or biased study interpretation does not negate the positive uses of IV magnesium post myocardial infarct (MI)

Posted by Dr Dan Carter, June 29, 2016 I was looking over a Facebook post today about the efficacy of IV Mg for MI, and it piqued my interest in looking at more recent research, since the post referred to studies from 1986 and 1992. In double-blind, placebo-controlled study, they looked at 273 patients who [...]

2018-01-18T01:40:07+00:00 June 30th, 2016|Categories: Uncategorized|

Arginine and glutamine improve wound healing

Posted by Dr Dan Carter, September 17, 2015 We cover all of the clinically significant amino acids in our advanced IV seminars. New information is constantly being generated and indexed on PubMed; this information is incorporated into our seminars so it is worthwhile to update your IV nutrient knowledge periodically - we recommend updates at [...]

2018-01-18T01:41:33+00:00 September 17th, 2015|Categories: Uncategorized|

Wallcur Practi bags – not quite finished

Posted by Dr Dan Carter FDA MedWatch came out with this safety alert yesterday. Thanks to Dr Tim Murbach for sending this to me. Simulated IV Solutions from Wallcur: CDER Statement- FDA’s Investigation into Patients being Injected [Posted 1/14/2015] AUDIENCE: Risk Manager, Health Professionals, Pharmacy ISSUE: FDA and the Centers for Disease Control and Prevention [...]

2018-01-18T01:43:45+00:00 January 15th, 2015|Categories: Uncategorized|

Wallcur Practi bag update – final?

Posted by Dr Dan Carter I relayed this information a couple of days ago via our IV chat line, and am including it in our blog to have a more permanent “information location” until this matter is concluded. See our two previous blog posts to get the full story. There are no warnings on the [...]

2018-01-18T01:45:18+00:00 January 7th, 2015|Categories: Uncategorized|

Update to Wallcur Practi IV Solution Bags – Urgent

Posted by Dr Dan Carter The FDA needs to take immediate and emergency action in the case of Wallcur Practi IV Solution Bags that are supposed to be used only for IV start practice. I (Dr Carter) received an email from a physician in Florida who has personal experience with the Practi Bags in question. [...]

2018-01-18T01:47:07+00:00 January 3rd, 2015|Categories: Uncategorized|

Importance of correct label reading hits the news

Posted by Dr Dan Carter Physicians who administer or supervise the administration of intravenous drugs and solutions know how critical it is to read the labels of these products before giving them to patients. IV set-up protocols normally require redundant reading of labels at least three times prior to administration, in order to insure that [...]

2018-01-18T01:48:57+00:00 December 31st, 2014|Categories: Uncategorized|

The TACT Trial – Presentation by PI* Dr Gervasio Lamas & the movie Unleaded

Posted by Dr Dan Carter I was fortunate to be present at a talk given by Dr Gervasio Lamas, the principle investigator *(PI) for the TACT (Trial to Assess Chelation Therapy) trial; he gave a good overview of the trial design and results at the ACAM spring meeting, held May 31-June 2, 2013. Dr. Lamas [...]

2018-01-18T01:52:29+00:00 September 1st, 2013|Categories: Uncategorized|

Trial to Assess Chelation Therapy (TACT) – The TACT Trial

Posted by Dr Dan Carter The Trial to Assess Chelation Therapy (TACT) was published in the Journal of the American Medical Association (JAMA) on March 27, 2013. The objective was to determine if an EDTA-based chelation treatment reduces cardiovascular events. The trail was a double-blind, placebo-controlled, 2 × 2 factorial randomized design, enrolling 1708 patients aged 50 [...]

2018-01-18T01:54:32+00:00 July 12th, 2013|Categories: Uncategorized|
Load More Posts